What does Spyre Therapeutics, Inc. do?
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage designed to bind…
What is Spyre Therapeutics, Inc.'s P/E and P/B ratio?
Spyre Therapeutics, Inc. has a P/E ratio of -48.1 and a P/B ratio of 7.84.
What is Spyre Therapeutics, Inc.'s debt-to-equity ratio?
Spyre Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does Spyre Therapeutics, Inc. owe compared with what it owns?
Spyre Therapeutics, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Spyre Therapeutics, Inc.'s Positivity rank?
Spyre Therapeutics, Inc. is ranked #5,737 of 6,775 companies globally and #3,175 of 4,000 in United States on PositoAI, with a Positivity Score of 15,907.
Does Spyre Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Spyre Therapeutics, Inc..
Where can I read the latest news about Spyre Therapeutics, Inc.?
Recent headlines about Spyre Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Spyre Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Spyre Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.